| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Swisher Daniel N Jr, Director
Received 1,500 shares by exercise or conversion ($19.7K) · Sold 1,500 shares ($111K) |
| 04 Nov 2026 |
Form 4: Maduck Sean, See Remarks
Received 11,841 shares by exercise or conversion ($97.9K) · Sold 11,841 shares ($964K) · Received 13,159 shares by exercise or conversion ($109K) · 1 more |
| 04 Nov 2026 |
Form 4: Vieira Roberto Wandenkolk, President, Oncology
Received 8,333 shares by exercise or conversion ($180K) · Sold 8,333 shares ($674K) |
| 16 Oct 2026 |
Form 4: Wilson James N, Director
Sold 10,000 shares ($1.15M) |
| 05 Oct 2026 |
Form 4: Vieira Roberto Wandenkolk, President, Oncology
Received 8,333 shares by exercise or conversion ($180K) · Sold 8,333 shares ($967K) |
| 05 Oct 2026 |
Form 4: Lyon Joseph Douglas, See Remarks
Received 810 shares by exercise or conversion ($11K) · Sold 810 shares ($93.5K) · Received 9,190 shares by exercise or conversion ($158K) · 1 more |
| 05 Oct 2026 |
Form 4: Maduck Sean, See Remarks
Received 413 shares by exercise or conversion ($3.42K) · Sold 413 shares ($47.7K) · Received 24,587 shares by exercise or conversion ($203K) · 1 more |
| 05 Oct 2026 |
Form 4: Gunn Justin Frederick, See Remarks
Granted 100,000 Stock Option (right to buy) |
| 28 Sep 2026 |
Form 4: Robb Gary Charles, Chief Business Officer
Gave 17,100 shares as a gift · Acquired 10,000 shares (Gift) |
| 18 Sep 2026 |
Form 4: Vieira Roberto Wandenkolk, President, Oncology
Sold 296 shares ($29.8K) |
| 18 Sep 2026 |
Form 4: Robb Gary Charles, Chief Business Officer
Received 17,493 shares by exercise or conversion ($145K) |
| 16 Sep 2026 |
Form 4: Lyon Joseph Douglas, See Remarks
Received 10,000 shares by exercise or conversion ($130K) · Sold 10,000 shares ($1.13M) |
| 16 Sep 2026 |
Form 4: Wilson James N, Director
Sold 10,000 shares ($1.11M) |
| 03 Sep 2026 |
Form 4: Guyer William, Chief Development Officer
Received 328 shares as a grant or award |
| 03 Sep 2026 |
Form 4: Maduck Sean, See Remarks
Received 25,000 shares by exercise or conversion ($207K) · Sold 25,000 shares ($2.86M) · Received 300 shares as a grant or award · 1 more |
| 03 Sep 2026 |
Form 4: Mokari Atabak, Chief Financial Officer
Received 276 shares as a grant or award · Gave up 102 shares to cover exercise price or tax ($11.6K) |
| 03 Sep 2026 |
Form 4: Robb Gary Charles, Chief Business Officer
Received 328 shares as a grant or award · Gave up 91 shares to cover exercise price or tax ($10.3K) |
| 03 Sep 2026 |
Form 4: Vieira Roberto Wandenkolk, President, Oncology
Received 276 shares as a grant or award · Gave up 102 shares to cover exercise price or tax ($11.6K) · Received 58,333 shares by exercise or conversion ($1.26M) · 1 more |
| 03 Sep 2026 |
Form 4: Lyon Joseph Douglas, See Remarks
Received 260 shares as a grant or award · Gave up 72 shares to cover exercise price or tax ($8.16K) |
| 28 Aug 2026 |
Form 4: Park Kimberly, Director
Received 30,000 shares by exercise or conversion ($405K) · Gave up 3,315 shares to cover exercise price or tax ($405K) · Sold 26,685 shares ($3.27M) |
Loading...